Intradermal delivery of a fractional dose of inactivated poliovirus vaccine (IPV) offers potential benefits compared to intramuscular (IM) delivery, including possible cost reductions and easing of IPV supply shortages. Objectives of this study were to assess intradermal delivery devices for dead space, wastage generated by the filling process, dose accuracy, and total number of doses that can be delivered per vial.
The Technical Network for Strengthening Immunization Services
We are a global network of immunization professionals committed to strengthening immunization services by building relationships, sharing knowledge, coordinating activities, and aligning priorities and goals. Learn More.
Looking for an immunization resource?
Our Knowledge Hub, built and curated by TechNet members, contains thousands of key immunization resources from around the world.
Home - TechNet-21
Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV)
Our community, our knowledge
6066 members
TechNet members are immunization professionals working to improve immunization services in every country and at all levels from global policy formulation and national programme management all the way to service delivery at subnational levels.
- Connect with each other and make new contacts
- Ask questions, provide answers, and share knowledge in our forum
- Join specialist groups (communities of practice)
- Track upcoming events, such as webinars, training opportunities and global events
- Browse key publications on Hot Topics curated by global experts
- Search for guidance in our Knowledge Hub
Our Partners
We are proud to work with many organizations and initiatives across the world in our efforts to help strengthen immunization services. We support the work of all immunization professionals, from both the public and private sector, from governments and international organizations to NGOs, academic institutions, companies and manufacturers. TechNet is a member of two global immunization partnerships: